Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk … C Schmid, M Labopin, A Nagler, M Bornhäuser, J Finke, A Fassas, ... Journal of clinical oncology 25 (31), 4938-4945, 2007 | 555 | 2007 |
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute … E Brissot, M Labopin, MM Beckers, G Socié, A Rambaldi, L Volin, J Finke, ... haematologica 100 (3), 392, 2015 | 164 | 2015 |
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors T Demirer, L Barkholt, D Blaise, P Pedrazzoli, M Aglietta, AM Carella, ... Nature clinical practice Oncology 5 (5), 256-267, 2008 | 107 | 2008 |
Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony‐stimulating factor (rhG‐CSF): a randomized evaluation of different doses … T Demirer, M Ayli, M Ozcan, N Gunel, R Haznedar, M Dagli, T Fen, ... British journal of haematology 116 (2), 468-474, 2002 | 93 | 2002 |
Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial Ç Baran, S Durdu, K Dalva, Ç Zaim, A Dogan, G Ocakoglu, G Gürman, ... Stem Cell Reviews and Reports 8, 963-971, 2012 | 78 | 2012 |
A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host … C Ustun, O Arslan, M Beksaç, H Koç, G Gurman, T Ozcelik, B Yilmaz, ... Biology of Blood and Marrow Transplantation 5 (1), 28-35, 1999 | 61 | 1999 |
Hepatitis B virus infection in allogeneic bone marrow transplantation C Üstün, H Koc, S Karayalçın, G Akyol, G Gürman, O Ilhan, H Akan, ... Bone marrow transplantation 20 (4), 289-296, 1997 | 58 | 1997 |
Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation T Demirer, H Celebi, M Arat, C Üstün, S Demirer, I Dilek, M Özcan, O Ilhan, ... Bone marrow transplantation 24 (3), 335-337, 1999 | 53 | 1999 |
Periodontal status and post‐transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation … CA Gürgan, M Özcan, Ö Karakuş, G Zincircioğlu, M Arat, E Soydan, ... International Journal of Dental Hygiene 11 (2), 84-90, 2013 | 50 | 2013 |
Expression of IFITM1 in chronic myeloid leukemia patients CB Akyerli, M Beksac, M Holko, M Frevel, K Dalva, U Özbek, E Soydan, ... Leukemia research 29 (3), 283-286, 2005 | 49 | 2005 |
Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease O Ilhan, M Arat, Ö Arslan, E Ayyildiz, H Sanli, M Beksac, M Özcan, ... Transfusion and apheresis science 30 (3), 185-187, 2004 | 48 | 2004 |
Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: a … S Eder, J Canaani, E Beohou, M Labopin, J Sanz, W Arcese, R Or, J Finke, ... American journal of hematology 92 (10), 997-1003, 2017 | 45 | 2017 |
Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. O Arslan, G Gürman, I Dilek, M Ozcan, H Koc, O Ilhan, H Akan, N Konuk, ... Haematologia 29 (1), 59-62, 1998 | 36 | 1998 |
Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia G Gürman, G Kahveci, O Ilhan, H Koç, M Beksaç, N Konuk, A Uysal Bone marrow transplantation 15 (3), 485-486, 1995 | 36 | 1995 |
Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell … M Özcan, C Üstün, E Akçağlayan, H Akan, Ö Arslan, O Ilhan, M Beksaç, ... Bone marrow transplantation 27 (5), 499-505, 2001 | 34 | 2001 |
The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation O İlhan, Ö Arslan, M Arat, M Beksaç, H Akan, M Özcan, G Gürman, ... Transfusion science 20 (1), 69-71, 1999 | 32 | 1999 |
Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single‐center study from Turkey H Sanli, M Arat, T Oskay, G Gürman International journal of dermatology 43 (3), 176-180, 2004 | 31 | 2004 |
Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield T Demirer, O Ilhan, M Ayli, M Arat, M Daglı, M Ozcan, R Haznedar, Y Genc, ... Therapeutic Apheresis 6 (5), 384-389, 2002 | 31 | 2002 |
HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemia. O Ihan, M Beksaç, O Arslan, M Ozcan, H Koç, H Akan, G Gürman, ... International journal of hematology 66 (3), 291-295, 1997 | 30 | 1997 |
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study MH Albert, T Sirait, DJ Eikema, K Bakunina, C Wehr, F Suarez, ML Fox, ... Blood, The Journal of the American Society of Hematology 140 (14), 1635-1649, 2022 | 27 | 2022 |